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Cryptogenic cerebral ischemia in young patients is commonly ascribed to paradoxical embolism. We report the clinical case of a young patient with cryptogenic stroke and a patent foramen ovale, undergoing percutaneous closure of atrial septal defect. Contrast transoesophageal echocardiography at the end of the procedure demonstrated massive late residual right-to-left shunt, due to coexistence of pulmonary arterio-venous fistulas that were subsequently closed. Routinary adoption of contrast transoesophageal echocardiography at the end of patent foramen ovale closure interventions may be useful to detect early and late residual shunts. Late residual shunts may be due to pulmonary fistulas, a well known risk factor for recurrent thromboembolic events.

 








Cryptogenic cerebral ischemia in young people is often ascribed to paradoxical embolism through atrial septal defects such as patent foramen ovale, whose prevalence in the general population is approximately 26%1. A rare cause of paradoxical embolism is the presence of a pulmonary arterio-venous fistula, whose estimated prevalence in the general population is 2-3 per 100.0002. In young patients with cryptogenic cerebral ischemia, the prevalence of patent foramen ovale rises up to 46%1, while a pulmonary arterio-venous fistula, isolated or associated with a patent foramen ovale, may be found in up to 15%2.
Contrast transoesophageal echocardiography may be useful for right-to-left shunt identification in patients with cryptogenic cerebral ischemia. Contrast appearance in left atrium within three cardiac cycles following complete opacification of the right atrium is supposed to distinguish an intracardiac from an extracardiac shunt3. In high-risk patients with patent foramen ovale suffering cryptogenic cerebral ischemia, septal defect closure is a safe and effective alternative to medical treatment4. Intraoperative transesophageal echocardiography is usually performed to guide the correct placement of the septal occluder device, while contrast transoesophageal echocardiography at the end of procedure is not routinary.

Case report 
A 26 years-old man referred to our Emergency Department complaining motor aphasia in the morning (lasted about 1 hour) followed by migraine with aura. On arrival he was eupneic, apiretic, with normal pulse oximetry (97%), regular heart rate (65 beats per minute), bilateral blood pressure of 100/70 mmHg. Physical examination was normal. He was then admitted to Neurology ward for further diagnostic tests.  Medical history collection revealed perinatal stroke, previous seizures, recurrent migraine and a patent foramen ovale, diagnosed the year before by transesophageal echocardiography. Cranial computed tomography scan and magnetic resonance imaging were performed and revealed recent ischemic, embolic lesions in the left temporal and frontal cerebral lobe. Additional diagnostic tests were performed to exclude other causes of cerebral ischemia. Carotid doppler, lower limbs venous ultrasound, electrocardiogram, 24-hour holter monitoring and laboratory tests were normal. 
The evidence of stroke in a patient with previously known patent foramen ovale strongly suggested paradoxical embolism. He was diagnosed with patent foramen ovale -related stroke and he was therefore planned for percutaneous closure of septal defect. 
Pre-procedural contrast transoesophageal echocardiography (performed with a Vivid 7 Dimension ultrasound machine, General Electric Healthcare, Norfolk, VA, USA) showed a massive early right-to-left shunt through patent foramen ovale. Percutaneous closure of atrial septal defect was performed using standardized techniques5,6, with transoesophageal echocardiography guidance. Balloon-sizing was avoided in order to prevent septal damage. A 18-mm Amplatzer patent foramen ovale occluder (St Jude Medical, Minneapolis, MN, USA) was implanted. 
At the end of the procedure, contrast transoesophageal echocardiography (Figure 1A) revealed correct placement of the device with resolution of the early right-to-left shunt, though a persistent and significant late shunt was still evident. Since a pulmonary arterio-venous fistula was suspected, an agitated saline injection in the pulmonary trunk was performed, showing left atrial opacification. A computed tomography angiogram was later performed and showed four pulmonary arterio-venous fistulas in the left lung inferior lobe (Figure 1C). The patient underwent percutaneous closure of three pulmonary arterio-venous fistulas (Figure 1B) with embolization coils (the fourth one was left untreated because of peripheral position and small size). At 6-months follow-up, the patient was asymptomatic, without further episodes of cerebral ischemia. The three pulmonary arterio-venous fistulas were completely closed on both pulmonary and computed tomography angiogram (Fig.1D/E), while contrast transoesophageal echocardiography showed a trivial residual shunt.

Discussion
Compared with medical therapy, percutaneous closure of atrial septal defects proved to be effective in the reduction of recurrent neurological events in patients with cryptogenic cerebral ischemia4, especially in those with a higher RoPE score7. However, despite the significant reduction of risk in patients undergoing patent foramen ovale closure, recurrent ischemic stroke may occur in 5.1% patients, as shown in a recent study by Seeger et al8.  Incident atrial fibrillation is a well known risk factor for recurrences4. Indeed, the presence of undiagnosed pulmonary arterio-venous fistula may explain further ischemic events9. Although unusual, contrast transoesophageal echocardiography at the end of patent foramen ovale closure interventions may be useful to detect early and late residual shunts. While early shunts may occur for unsatisfying device deployment, late shunts may be due to the presence of extracardiac shunts such as pulmonary arterio-venous fistula. This simple and safe practice can occasionally identify extracardiac right-to-left shunts that, if left untreated, might explain recurrent thromboembolic events in patients with a technically successful patent foramen ovale closure intervention10.

Conclusions
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Figure 1 – Patent foramen ovale closure with pulmonary arterio-venous fistulas (PAVFs) detection and treatment. Panel A: intraoperative Contrast transoesophageal echocardiography showing correct deployment of the occluder device but persistence of late shunt in the left atrium. Panel B/C: pulmonary/CT angiogram showing one of the four PAVFs before its percutaneous closure. Panel D: post-procedural pulmonary angiogram showing closed PAVFs. Panel E: six-months CT-angiogram showing good results of PAVFs closure over time.
Video 1 – PFO closure angiogram and Contrast transoesophageal echocardiography showing correct placement of the device but persistence of massive late right to left shunt.
Video 2 – Percutaneous closure of pulmonary fistulas.
Video 3 – 6-months 3D-CT-angiogram reconstruction.
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